Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Telcagepant 140 mg
DRUG
2 trials
Sponsors
Merck Sharp & Dohme LLC
Conditions
Migraine
Migraines
Phase 2
MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)
Terminated
NCT00797667
Merck Sharp & Dohme LLC
Migraine
Start: 2008-11-12
End: 2009-05-20
Updated: 2018-10-18
Phase 3
Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)
Completed
NCT00483704
Merck Sharp & Dohme LLC
Migraines
Start: 2008-08-14
End: 2009-03-25
Updated: 2018-10-18
Related Papers
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.
2014-08-08
188 citations
Randomized, controlled trial of telcagepant over four migraine attacks.
2010-06-08
55 citations